Organon & Co.
$13.4
USD
Last updated on --.
24h volume2.63M
24h highest13.4400 USD
24h lowest13.3900 USD
24h Price movement-0.22%
OGN recent prices
24 Hours
-0.22%-$0.03
30 days
+2.01%+$0.265
60 days
+129.97%+$7.590
90 days
+85.68%+$6.195
Key data
Previous close13.4300 USD
Market cap3.53B USD
Volume2.63M
P/E ratio14.370000
Dividend yield (TTM)0.01%
Dividend amount0.020000 USD
Next ex-dividend date11 May 2026
Next payment date11 June 2026
EPS diluted (TTM)0.94000 USD
Net income (FY)246.00M USD
Revenue (FY)6.16B USD
Last report date4 May 2026
About Organon & Co.
HeadquartersJERSEY CITY
Employees (FY)10.00K
Revenue per employee (FY)616.30K USD
Net income per employee (FY)24.60K USD
Listed onNew York Stock Exchange
OGN conversion tables
 |  |
|---|---|
| 0.5 OGN | 6.700 USD |
| 1 OGN | 13.4 USD |
| 5 OGN | 67 USD |
| 10 OGN | 134 USD |
| |
|---|---|
| 0.5 USD | 0.037313 OGN |
| 1 USD | 0.074627 OGN |
| 5 USD | 0.37313 OGN |
| 10 USD | 0.74627 OGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
OGN is trading at $13.40, -0.22% over the last 24 hours. Track live moves on the price chart at the top of this page.
The OGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. OGN is currently trading at $13.40, -0.22% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on OGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. OGN's P/E ratio is currently 14.370000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from OGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against OGN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Organon & Co.'s market cap is currently 3.53B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.63M
24h highest13.4400 USD
24h lowest13.3900 USD
24h Price movement-0.22%
Start trade with OGN Perpetual
Sign up to trade